Ipsen Hot Bending Furnace

Ipsen is a global biopharmaceutical company headquartered in Paris, France, specializing in the development and commercialization of innovative medicines across three key therapeutic areas: oncology, neuroscience, and rare diseases. Founded in 1929 by Henri Beaufour, the company has grown into a leader in the pharmaceutical industry, with a strong focus on research and development. Ipsen operates in over 100 countries and employs more than 5,700 people worldwide. The company is committed to improving patients' lives by delivering high-quality, effective treatments, and it has a robust pipeline of products addressing unmet medical needs. Ipsen also emphasizes sustainability and corporate responsibility, striving to make a positive impact on society and the environment. Ipsen's brand culture is deeply rooted in innovation, patient-centricity, and scientific excellence. As a global biopharmaceutical company, Ipsen is committed to discovering, developing, and delivering transformative medicines in oncology, rare diseases, and neuroscience. The company fosters a culture of collaboration, integrity, and sustainability, striving to make a meaningful impact on patients' lives. Ipsen emphasizes agility and forward-thinking, leveraging cutting-edge research and partnerships to address unmet medical needs. With a focus on ethical practices and social responsibility, Ipsen aims to create long-term value for patients, healthcare professionals, and society as a whole. Ipsen is a global biopharmaceutical company with a strong brand influence in the healthcare and pharmaceutical industry. Known for its commitment to innovation and patient-centric solutions, Ipsen has established itself as a trusted leader in areas such as oncology, neuroscience, and rare diseases. The company’s reputation is built on its rigorous research and development, high-quality products, and dedication to improving patient outcomes. With a presence in over 100 countries, Ipsen’s brand is synonymous with scientific excellence, ethical practices, and a focus on addressing unmet medical needs. Its strategic partnerships, continuous investment in cutting-edge therapies, and global outreach further enhance its influence and recognition in the pharmaceutical sector.